The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1

Qibin Xu
DOI: https://doi.org/10.2147/OTT.S283110
IF: 4
2020-10-07
OncoTargets and Therapy
Abstract:Xu Q. Onco Targets Ther . 2020;13:7839–7849. At the request of the author, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The author contacted the journal after realising the Y79 cells had been mixed up with HEK-293T cells following a labelling error and the wrong results had been reported for the Y79 cell line. The author was unable to provide satisfactory raw data for the western blots shown in Figure 5F and was also unable to provide the original images shown in Figure 6A. The editor determined the findings of the article were no longer valid and agreed with the authors request to retract the article. The author wishes to apologise for this error. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as "Retracted". This retraction relates to this paper
oncology,biotechnology & applied microbiology
What problem does this paper attempt to address?